期刊文献+

阿替普酶联合华法林治疗大面积肺栓塞患者的临床效果评价

Evaluation of the Clinical Effectiveness of Alteplase Combined with Warfarin in the Treatment of Patients with Massive Pulmonary Embolism
下载PDF
导出
摘要 目的:探究阿替普酶联合华法林治疗大面积肺栓塞的疗效。方法:选取2016年1月—2021年1月于佛山市南海区人民医院收治的62例大面积肺栓塞患者资料,随机分为观察组与对照组,各31例。观察组予以阿替普酶联合华法林治疗,对照组予以肝素联合华法林治疗。比较两组疗效、凝血功能、血气分析指标、右心功能及不良反应。结果:观察组疗效有效率高于对照组,差异有统计学意义(P=0.003);治疗后,观察组凝血酶原时间、活化部分凝血活酶时间、凝血酶时间、纤维蛋白原水平低于对照组,差异有统计学意义(P<0.05);治疗后,观察组血氧分压、血二氧化碳分压水平高于对照组,心肌肌钙蛋白I水平低于对照组,差异有统计学意义(P<0.05);治疗后,观察组肺动脉压、右室直径、三尖瓣反流差压低于对照组,差异有统计学意义(P<0.001)。结论:阿替普酶联合华法林治疗大面积肺栓塞效果显著,安全性高,且可有效改善心功能损伤、凝血功能、血气分析指标。 Objective:To investigate the efficacy of alteplase combined with warfarin in the treatment of massive pulmonary embo⁃lism.Methods:Sixty-two cases of patients with massive pulmonary embolism admitted to the Foshan Nanhai District People's Hos⁃pital from January 2016 to January 2021 were selected and randomly divided into the observation group and the control group,each with thirty-one cases.The observation group was treated with alteplase combined with warfarin,and the control group was treated with heparin combined with warfarin.The two groups were compared in terms of efficacy,coagulation function,blood gas analysis indexes,right heart function and adverse reactions.Results:The efficacy of the observation group was higher than that of the control group,and the difference was statistically significant(P=0.003);After treatment,prothrombin time,activated partial thromboplastin time,prothrombin time and fibrinogen level of the observation group were lower than that of the control group,and the difference was statistically significant(P<0.05);After treatment,the levels of blood oxygen partial pressure and blood carbon dioxide partial pressure of the observation group were higher than those of the control group,and the level of cardiac troponin I was lower than that of the control group,and the difference was statistically significant(P<0.05);After treatment,pulmonary artery pressure,right ventricular diameter,and tricuspid regurgitation difference of the observation group were lower than that of the con⁃trol group,and the difference was statistically significant(P<0.001).Conclusion:Alteplase combined with warfarin is effective and safe in the treatment of massive pulmonary embolism,and it can effectively improve cardiac function impairment,coagulation func⁃tion,and blood gas analysis indexes.
作者 罗健成 Luo Jiancheng(Foshan Nanhai District People's Hospital,Foshan 528200,Guangdong Province,China)
出处 《中外医药研究》 2023年第26期63-65,共3页 JOURNAL OF CHINESE AND FOREIGN MEDICINE AND PHARMACY RESEARCH
关键词 阿替普酶 华法林 肺栓塞 肝素 Alteplase Warfarin Pulmonary embolism Heparin
  • 相关文献

二级参考文献77

  • 1荆志成,邓可武.急性肺动脉血栓栓塞症的溶栓治疗[J].中华医学杂志,2004,84(22):1932-1934. 被引量:20
  • 2邹治鹏,何建国,程显声,赵彦芬,陈白屏,高莹,熊长明,倪新海,荆志诚.230例急性肺动脉血栓栓塞症患者对症治疗、抗凝治疗和溶栓治疗的住院转归[J].中国循环杂志,2006,21(3):219-221. 被引量:27
  • 3国家"十五"攻关"肺栓塞规范化诊治方法的研究"课题组,杨媛华,翟振国,武燕兵,王辰.急性肺血栓栓塞症患者516例临床表现分析[J].中华医学杂志,2006,86(31):2161-2165. 被引量:78
  • 4Yalamanchili K, Fleisher AG, Lehrman SG, et al. Open pulmonary embolectomy for treatnlent of major pulmonary embolism. Ann Thorae Surg, 2004,77:819-823.
  • 5Hann CL, Streiff MB. The role of vena caval filters in the management of venous thromboembolism. Blood Rev, 2005, 19 : 179-202.
  • 6PREPIC Study Group. Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Prevention du Risque d' Embolie Pulmonaire par Interruption Cave) randomized study. Circulation, 2005,112:416-422.
  • 7Karmy-Jones R, Jurkovich GJ, Velmahos GC, et al. Practice patterns and outcomes of retrievable vena cava filters in trauma patients : an AAST multicenter study. J Trauma, 2007,62 : 17-24.
  • 8Barral FG. Vena cava filters: why, when, what and how? J Cardiovasc Surg (Torino) , 2008,49:35-49.
  • 9Meyer G, Sors H, Charbonnier B, et al. Effects of intravenous urokinase versus alteplase on total pulmonary resistance in acute massive pulmonary embolism : a European nmlticenter double-blind trial. The European Cooperative Study Group for Pulmonary Embolism. J Am Coll Cardiol, 1992, 19:239-245.
  • 10Dalla-Volta S, Palla A, Santolicandro A, et al. PALMS 2: aheplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. Plasminogen activator Italian multicenter study 2. J Am Coll Cardiol, 1992, 20:520-526.

共引文献1370

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部